S. 4109Introduced
Stem Cell Therapeutic and Research Reauthorization Act of 2026
Reauthorizes federal stem cell therapeutic and research programs through 2029 to continue related treatment and research activities
Plain-English overview
What this bill does
Reauthorizes federal stem cell therapeutic and research programs through 2029 to continue related treatment and research activities
Key points
- Extend stem cell programs
Current status
Where it stands
Status
Introduced
Latest action
2026-06-22 — Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.
Related context
Topics and policy areas
undefinedBiological and life sciencesBlood and blood diseasesCell biology and embryologyHealthHealth programs administration and fundingOrgan and tissue donation and transplantation